About This Stock
More About This Stock
Latest Posts
1 to 3 of 3 Posts
Cantor Fitzgerald's Caroline Corner: Cutting-Edge Devices And Diagnostics Deliver Drugs And Profits
Article By:
The Life Sciences Report
Tuesday, August 4, 2015 11:47 AM EDT
Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. Corner brings important names to investors' attention.
In this article: AGN, AEMD, CERS, D-STEM (DEFUNCT), NVIV, AERI, GKOS Also: RHHBY, ALIM, REGN, ONVO, XENT, MRK
Zacks' Jason Napodano Is Not Focused On A Biotech Bubble
Article By:
The Life Sciences Report
Thursday, July 9, 2015 8:45 AM EDT
Jason Napodano, CFA, of Zacks Investment Research details the upside for small-cap biotech names that he believes will be huge gainers for investor portfolios.
In this article: BCLI, CUR, CYNAF, GSK, NVIV Also: NBI, ACOR, AMGN, BIIB, BLUE, CELG, DEPO, GILD, IBB, JUNO, KITE, LLY, MD, PFE, RVXCF, D-STEM (DEFUNCT), SYK
TPI Expects To Receive GMP By End Of 2014; NVIV Reports FDA Approval To Expedite Enrollment For Pilot Trial
Article By:
BioMedReports
Wednesday, December 17, 2014 4:27 AM EDT
(TPI) Expects to receive GM, (NVIV) announced approval by the U.S. FDA for an expedited enrollment plan for the company’s ongoing pilot trial of its investigational Neuro-Spinal Scaffold.
1 to 3 of 3 Posts